FDA provides update on adverse events associated with breast implants

[News]

Today, the U.S. Food and Drug Administration is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and systemic signs and symptoms referred to by patients as breast implant illness (BII), which some patients report after receiving breast implants.

More... (https://www.news-medical.net/news/20200820/FDA-provides-update-on-adverse-events-associated-with-breast-implants.aspx)